Tirzepatide · 2026-09-10
ClinicalTrials.gov record NCT07812636
Not yet recruiting at the retained observation.
Open attributed record →Official registry phase
11 selected ClinicalTrials.gov records carrying the official Early Phase 1 designation. Phase is reported exactly as supplied by the retained registry version; records without a supplied phase are not inferred into this page.
11 selected records.
6 profiles.
ClinicalTrials.gov phase field.
Attributed registry records
Tirzepatide · 2026-09-10
Not yet recruiting at the retained observation.
Open attributed record →Tirzepatide · 2026-07-15
Recruiting at the retained observation.
Open attributed record →Gallium Ga 68 dotatate · 2026-03-31
Active, not recruiting at the retained observation.
Open attributed record →Ganirelix · 2025-09-11
Active, not recruiting at the retained observation.
Open attributed record →Ganirelix · 2025-04-27
Completed at the retained observation.
Open attributed record →Teduglutide · 2023-11-29
Completed at the retained observation.
Open attributed record →Enfuvirtide · 2021-11-23
Completed at the retained observation.
Open attributed record →Cetrorelix · 2019-07-11
Completed at the retained observation.
Open attributed record →Ganirelix · 2017-12-26
Completed at the retained observation.
Open attributed record →Ganirelix · 2016-07-04
Completed at the retained observation.
Open attributed record →Cetrorelix · 2015-12-29
Completed at the retained observation.
Open attributed record →